Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR. Chen WC, et al. Among authors: bi wl. Nat Med. 2023 Dec;29(12):3067-3076. doi: 10.1038/s41591-023-02586-z. Epub 2023 Nov 9. Nat Med. 2023. PMID: 37944590 Free PMC article.
ARID1A and TERT promoter mutations in dedifferentiated meningioma.
Abedalthagafi MS, Bi WL, Merrill PH, Gibson WJ, Rose MF, Du Z, Francis JM, Du R, Dunn IF, Ligon AH, Beroukhim R, Santagata S. Abedalthagafi MS, et al. Among authors: bi wl. Cancer Genet. 2015 Jun;208(6):345-50. doi: 10.1016/j.cancergen.2015.03.005. Epub 2015 Mar 18. Cancer Genet. 2015. PMID: 25963524 Free PMC article.
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Aizer AA, Abedalthagafi M, Bi WL, Horvath MC, Arvold ND, Al-Mefty O, Lee EQ, Nayak L, Rinne ML, Norden AD, Reardon DA, Wen PY, Ligon KL, Ligon AH, Beroukhim R, Dunn IF, Santagata S, Alexander BM. Aizer AA, et al. Among authors: bi wl. Neuro Oncol. 2016 Feb;18(2):269-74. doi: 10.1093/neuonc/nov177. Epub 2015 Aug 30. Neuro Oncol. 2016. PMID: 26323607 Free PMC article.
Checkpoint inhibition in meningiomas.
Bi WL, Wu WW, Santagata S, Reardon DA, Dunn IF. Bi WL, et al. Immunotherapy. 2016 Jun;8(6):721-31. doi: 10.2217/imt-2016-0017. Immunotherapy. 2016. PMID: 27197540 Review.
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Mei Y, Bi WL, Greenwald NF, Du Z, Agar NY, Kaiser UB, Woodmansee WW, Reardon DA, Freeman GJ, Fecci PE, Laws ER Jr, Santagata S, Dunn GP, Dunn IF. Mei Y, et al. Among authors: bi wl. Oncotarget. 2016 Nov 22;7(47):76565-76576. doi: 10.18632/oncotarget.12088. Oncotarget. 2016. PMID: 27655724 Free PMC article.
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, Batchelor TT, Ligon KL, Ligon AH, Meyerson M, Dunn IF, Beroukhim R, Louis DN, Perry A, Carter SL, Giannini C, Curry WT Jr, Cahill DP, Barker FG 2nd, Brastianos PK, Santagata S. Shankar GM, et al. Among authors: bi wl. Neuro Oncol. 2017 Apr 1;19(4):535-545. doi: 10.1093/neuonc/now235. Neuro Oncol. 2017. PMID: 28170043 Free PMC article.
Radiographic prediction of meningioma grade by semantic and radiomic features.
Coroller TP, Bi WL, Huynh E, Abedalthagafi M, Aizer AA, Greenwald NF, Parmar C, Narayan V, Wu WW, Miranda de Moura S, Gupta S, Beroukhim R, Wen PY, Al-Mefty O, Dunn IF, Santagata S, Alexander BM, Huang RY, Aerts HJWL. Coroller TP, et al. Among authors: bi wl. PLoS One. 2017 Nov 16;12(11):e0187908. doi: 10.1371/journal.pone.0187908. eCollection 2017. PLoS One. 2017. PMID: 29145421 Free PMC article.
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
Huang RY, Unadkat P, Bi WL, George E, Preusser M, McCracken JD, Keen JR, Read WL, Olson JJ, Seystahl K, Le Rhun E, Roelcke U, Koeppen S, Furtner J, Weller M, Raizer JJ, Schiff D, Wen PY. Huang RY, et al. Among authors: bi wl. Neuro Oncol. 2019 Feb 14;21(2):234-241. doi: 10.1093/neuonc/noy126. Neuro Oncol. 2019. PMID: 30085283 Free PMC article.
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Huang RY, Bi WL, Weller M, Kaley T, Blakeley J, Dunn I, Galanis E, Preusser M, McDermott M, Rogers L, Raizer J, Schiff D, Soffietti R, Tonn JC, Vogelbaum M, Weber D, Reardon DA, Wen PY. Huang RY, et al. Among authors: bi wl. Neuro Oncol. 2019 Jan 1;21(1):26-36. doi: 10.1093/neuonc/noy137. Neuro Oncol. 2019. PMID: 30137421 Free PMC article. Review.
216 results